Sagimet Biosciences Inc Series A Common Stock

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
$0
EBITDA
-16,902
-10,589
-8,768
-6,780
EBIT
-21,178
-17,536
-16,246
Net Income
-14,619
-8,118
-6,629
-8,151
Net Change In Cash
0
0
0
0
Free Cash Flow
-19,569
-5,634
-6,208
-7,083
Cash
77,014
95,959
176,777
75,139
Basic Shares
32,143
31,913
29,039
18,194

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$2,000
$0
$0
$0
Gross Profit
2,000
-130
-134
-124
EBITDA
-30,740
-31,055
-23,719
-11,246
EBIT
-61,484
-31,055
-23,719
-11,370
Net Income
-27,876
-30,499
-24,442
-11,370
Net Change In Cash
2,000
0
0
0
Free Cash Flow
-23,766
-24,490
-21,710
-10,416
Cash
75,139
158
56,731
68,702
Basic Shares
10,460
22,174
22,174
22,174

Earnings Calls

Quarter EPS
2024-09-30
-$0.45
2024-06-30
-$0.25
2024-03-31
-$0.23
2023-12-31
-$0.78